Atul has disclosed a US customs investigation involving its wholly owned subsidiary, Atul USA Inc, over alleged evasion of anti-dumping and countervailing duties on imports of 2,4-Dichlorophenoxyacetic Acid, or 2,4-D, and its derivatives. The company denies the allegation at this preliminary stage and says the impact is uncertain.
The November 19 exchange filing reports both an investigation and an interim measure affecting covered import entries. It does not disclose a final finding of evasion, a penalty amount or a quantified financial liability.
The allegation concerns the route of covered imports
According to Atul’s disclosure, US Customs and Border Protection, or CBP, suspects that Chinese-origin 2,4-D and its derivatives were transhipped through India to the United States, raising questions about the anti-dumping and countervailing duties applicable to those imports. The investigation is against Atul USA Inc.
Those are allegations described in the company’s filing, not facts independently established by this report. Atul says it has engaged US-based lawyers for advice and guidance. The disclosure does not provide the lawyers’ assessment or predict the outcome.
An interim customs measure is already in place
The filing says CBP has suspended liquidation of each unliquidated entry of covered merchandise that entered the United States after August 11, 2026, or as permitted by law. It adds that CBP may take further measures to protect US revenue.
That stated measure concerns covered customs entries. The announcement does not describe a company-wide operating shutdown, an across-the-board import ban or a final penalty. Those wider conclusions should not be inferred from the notice.
The financial question remains open
Atul says it received a copy of the public version of the notice on November 18 at 21:50 IST. It disclosed the matter to the exchanges on November 19. The filing calls the impact uncertain and does not give a monetary estimate.
For readers following the matter, the next useful evidence would be a further company disclosure or an official determination that clarifies the allegations, measures and financial exposure. For now, the confirmed development is an investigation with an interim covered-entry measure, alongside the company’s denial, not an established loss or a resolved case.
